Katharina Morwald

Salzburg, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

The Use of Body Mass Index Polygenic Risk Score (BMI-PRS) in a Paediatric Population With Obesity.

The Use of Body Mass Index Polygenic Risk Score (BMI-PRS) in a Paediatric Population With Obesity.

Journal: Pediatric obesity

Published: January 31, 2026

Correction: Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS.

Correction: Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS.

Journal: Cardiovascular diabetology

Published: November 02, 2025

The GLP-1 Agonist Exenatide Is Associated with Improved Adherence to Health Behavior and Lifestyle Treatment in Adolescents with Obesity: A Randomized Controlled Trial.

The GLP-1 Agonist Exenatide Is Associated with Improved Adherence to Health Behavior and Lifestyle Treatment in Adolescents with Obesity: A Randomized Controlled Trial.

Journal: Obesity facts

Published: October 29, 2025

Combining GLP-1 Receptor Agonists and Health-Behaviour and Lifestyle Therapy Yields Higher Adherence and Reduces Session Needs for Successful Weight Management in Adolescence: An Observational Real-World Single-Center Study.

Combining GLP-1 Receptor Agonists and Health-Behaviour and Lifestyle Therapy Yields Higher Adherence and Reduces Session Needs for Successful Weight Management in Adolescence: An Observational Real-World Single-Center Study.

Journal: Pediatric obesity

Published: September 19, 2025

Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS.

Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS.

Journal: Cardiovascular diabetology

Published: April 14, 2025

Validation of Fat Mass Metrics in Pediatric Obesity.

Validation of Fat Mass Metrics in Pediatric Obesity.

Journal: Annals of nutrition & metabolism

Published: July 04, 2024

Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes.

Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes.

Journal: Frontiers in endocrinology

Published: January 10, 2024

Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control.

Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control.

Journal: Frontiers in endocrinology

Published: September 12, 2023

Studies in children with obesity in two European treatment centres show a high prevalence of impaired glucose metabolism in the Swedish cohort.

Studies in children with obesity in two European treatment centres show a high prevalence of impaired glucose metabolism in the Swedish cohort.

Journal: Acta paediatrica (Oslo, Norway : 1992)

Published: January 30, 2023

Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial.

Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial.

Journal: Annals of nutrition & metabolism

Published: December 08, 2022

The relationship between glucose and the liver-alpha cell axis - A systematic review.

The relationship between glucose and the liver-alpha cell axis - A systematic review.

Journal: Frontiers in endocrinology

Published: October 04, 2022

Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease.

Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease.

Journal: Frontiers in endocrinology

Published: July 26, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026